Erica L. Liebelt
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Sprint (United States) (2012); Boston Children's Hospital (1992–1999); Geisinger Medical Center (1997–2003); Lurie Children's Hospital (1999); Seattle Children's Hospital (1999); St. Vincent's Birmingham (2005); Nationwide Children's Hospital (1999); Yale New Haven Hospital (1996); Cardinal Glennon Children’s Medical Center (1999); Children's Mercy Hospital (1999); NewYork–Presbyterian Hospital (1997); Harvard University (1994); Johns Hopkins University (1998–2001); University of Massachusetts Chan Medical School (1998); University of Alabama (2004–2014); Prudential Financial (United States) (2012); University of Washington (1999); Loma Linda University (2006); Johns Hopkins Medicine (1998–2001); Good Samaritan Medical Center (2006); Society of Toxicology (2006); Denver Health Medical Center (2006); Johns Hopkins Bayview Medical Center (2001); Palmetto Health Richland (2006); Children's of Alabama (2003–2018); University of Alabama at Birmingham (2003–2022); Yale University (1994–1999); In-Q-Tel (2004–2005); Regional Center for Poison Control and Prevention (1993); Northwestern Memorial Hospital (1999); Washington Poison Center (2018–2021); Mercy Hospital (1999); Food and Drug Administration (2012); Children's Hospital & Medical Center (1999); Johns Hopkins Hospital (2001); Children's Hospital (2008); Chemopharma (Austria) (2000); Geisinger Health System (2000); Penn State Milton S. Hershey Medical Center (1999); University of Colorado Denver (2006)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Erica L. Liebelt's research focuses on the toxicology of various substances and their impact on human health, particularly concerning exposures reported to poison control centers. Her work has investigated trends in overdose, abuse, and misuse of substances such as diphenhydramine and synthetic cannabinoids within the United States. Liebelt has also examined exposures related to kratom among older adults and suspected suicidal cannabis exposures.
Her publications include analyses of manufactured cannabis products and cannabis plant products, as well as a study on acute hypersensitivity reactions by antivenom type. Liebelt's scholarship metrics indicate a significant body of work, with an h-index of 28, 80 total publications, and 2,300 total citations. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Laura P. James and Jennifer L. Perry.
Liebelt's research interests align with understanding patterns of substance use and exposure, contributing to public health data and informing potential interventions. Her recent work extends to a 2025 publication analyzing snake bite registry data, demonstrating a broad scope within the field of toxicology and emergency medicine.
Metrics
- h-index: 28
- Publications: 80
- Citations: 2,311
Selected Publications
-
Decontamination (2026)
-
Analysis of Acute Hypersensitivity Reactions by Antivenom Type and Geographic Location in the North American Snake Bite Registry (NASBR) (2025)
-
Impact of the Coronavirus Disease 2019 Pandemic on Clinical Trends in Pediatric Intentional Self-Poisonings (2025)
-
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)
-
Suspected Suicidal Cannabis Exposures Reported to US Poison Centers, 2009-2021 (2023)
-
Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department (2022)
-
Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019 (2022)
-
Methylene Blue (2021)
-
Kratom exposures among older adults reported to U.S. poison centers, 2014–2019 (2021)
-
Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019 (2021)
Collaboration Network
Top Collaborators
- Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019
- Suspected Suicidal Cannabis Exposures Reported to US Poison Centers, 2009-2021
- Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019
- Suspected Suicidal Cannabis Exposures Reported to US Poison Centers, 2009-2021
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019
- Suspected Suicidal Cannabis Exposures Reported to US Poison Centers, 2009-2021
- Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Kratom exposures among older adults reported to U.S. poison centers, 2014–2019
- Methylene Blue
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
- Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations
Similar Researchers
Based on overlapping research topics